Home> Products> management of idiopathic pulmonary fibrosis

{ "products": [ { "_id": "68272992e579986392b124bf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NINTEPRIDE 150", "description": "NINTEPRIDE 150 is a prescription medication that contains Nintedanib 150 mg, a targeted therapy used primarily in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and certain types of non-small cell lung cancer (NSCLC). It works by slowing the progression of fibrotic diseases, helping to maintain better lung function and improving the patient's quality of life.\n\nKey Ingredient\nNintedanib (150 mg)\nNintedanib is a tyrosine kinase inhibitor that blocks several growth factor receptors responsible for promoting fibrosis and tumor growth. It is an orally administered compound used in chronic and progressive lung conditions.\n\nKey Benefits\nHelps slow down the progression of idiopathic pulmonary fibrosis (IPF).\n\nImproves lung function and delays further decline in lung capacity.\n\nUsed as a treatment for systemic sclerosis-associated interstitial lung disease (SSc-ILD).\n\nBeneficial in certain types of advanced non-small cell lung cancer (NSCLC).\n\nTargets multiple pathways involved in fibrosis and tumor progression.\n\nProvides a convenient oral dosage form for chronic conditions.\n\nHow Does It Work?\nNINTEPRIDE 150 (Nintedanib 150 mg) works by inhibiting multiple receptor tyrosine kinases, including those for platelet-derived growth factor (PDGF), fibroblast growth factor (FGF), and vascular endothelial growth factor (VEGF). These growth factors are responsible for the development and progression of fibrosis and abnormal cell proliferation. By blocking these receptors, Nintedanib helps to:\n\nReduce the formation of scar tissue in the lungs.\n\nDecrease inflammation and tissue remodeling.\n\nInhibit tumor angiogenesis in certain cancer types.\n\nPreserve lung structure and function over time.\n\nDirections for Use\nNINTEPRIDE 150 should be taken orally, twice daily (usually one capsule in the morning and one in the evening).\n\nTake the capsule with food and water to reduce the risk of gastrointestinal side effects.\n\nDo not chew or crush the capsule; swallow it whole.\n\nTake the medication at the same times each day for optimal results.\n\nFollow the dosage and schedule prescribed by your healthcare provider.\n\nIf a dose is missed, skip it and continue with the next scheduled dose. Do not take a double dose.\n\nSide Effects\nNINTEPRIDE 150 may cause some common and serious side effects. It is important to report any persistent or severe symptoms to a healthcare professional.\n\nCommon Side Effects:\n\nDiarrhea\n\nNausea\n\nVomiting\n\nLoss of appetite\n\nWeight loss\n\nAbdominal pain\n\nLiver enzyme elevation\n\nSerious Side Effects:\n\nSevere liver problems\n\nBleeding complications\n\nGastrointestinal perforation\n\nHeart-related issues such as increased blood pressure or myocardial infarction\n\nHypersensitivity reactions including rash, itching, or swelling\n\nRegular liver function monitoring and clinical follow-up are essential while on NINTEPRIDE 150 to ensure safe and effective use.", "price": 1050.0, "discountamount": 315.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "nintepride 150", "tumor progression", "capsule swallow", "promoting fibrosis", "nintepride 150nintepride 150", "scheduled dose", "chronic conditions", "lung function", "prescription medication", "ensure safe", "clinical followup", "rash itching", "severe symptoms", "missed skip", "healthcare provider", "schedule prescribed", "time directions", "scar tissue", "growth factors", "lung capacity", "tumor growth", "patients quality", "targeted therapy", "nintedanib 150 mg", "side effects", "gastrointestinal side effects", "orally administered compound", "receptors nintedanib helps", "increased blood pressure", "optimal results follow", "lungs decrease inflammation", "abnormal cell proliferation", "tyrosine kinase inhibitor", "fibrotic diseases helping" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2116, "imageuri": "https://productimages.withfloats.com/actual/682729941972da8c8f537bca.png", "tileimageuri": "https://productimages.withfloats.com/tile/682729941972da8c8f537bca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-16T12:03:30.781Z", "updatedon": "2025-05-16T12:03:30.781Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintepride-150/2116", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Nintedanib 150mg", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib (100 mg)", "description": "NINTEDONE 100 \nNintedanib (100 mg)\nNINTEDONE 100 is a potent pharmaceutical formulation containing Nintedanib, a key ingredient known for its efficacy in treating idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases. Nintedanib works by inhibiting multiple pathways that lead to fibrosis, making it a crucial medication for managing progressive lung conditions. This product is designed to slow the progression of these diseases, helping patients maintain lung function and improve their quality of life.\n\n \nKey Ingredients:\n \n\nNintedanib (100 mg): Nintedanib is a tyrosine kinase inhibitor that targets multiple receptors involved in the fibrotic process, including the platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), and vascular endothelial growth factor receptor (VEGFR). By inhibiting these pathways, Nintedanib reduces the formation of fibrous tissue, thereby slowing disease progression.\n \n\nKey Benefits:\n \n\nSlows Disease Progression: Nintedanib 100 mg is clinically proven to slow the decline in lung function in patients with idiopathic pulmonary fibrosis, extending the time before the disease becomes more severe.\nReduces Exacerbations: This medication decreases the frequency of acute exacerbations, which are sudden worsenings of symptoms that can lead to hospitalization.\nImproves Quality of Life: By managing the symptoms and progression of IPF, NINTEDONE 100 helps patients maintain their daily activities and overall well-being.\n \n\nHow Does It Work?\n\nNintedanib, the active ingredient in NINTEDONE 100, works by inhibiting the activity of tyrosine kinases, enzymes involved in the signaling pathways that lead to fibrosis. Specifically, Nintedanib blocks the receptors for platelet-derived growth factor, fibroblast growth factor, and vascular endothelial growth factor, which are key players in the development of fibrotic tissue. By interrupting these pathways, Nintedanib reduces the formation of scar tissue in the lungs, thereby slowing the progression of IPF and other fibrotic diseases.\n\n \n\nDirections for Use:\n \n\nDosage: The recommended dosage of NINTEDONE 100 is one capsule taken twice daily, approximately 12 hours apart, with food. It is important to follow the prescribed dosage and not to alter or discontinue use without consulting a healthcare provider.\nAdministration: Swallow the capsule whole with a glass of water. Do not crush or chew the capsule, as this may affect the absorption and efficacy of the medication.\n \n\nSide Effects:\n\nAs with any medication, NINTEDONE 100 may cause side effects. Common side effects include:\n\nGastrointestinal Issues: Diarrhea, nausea, vomiting, and abdominal pain are the most frequently reported side effects.\nLiver Enzyme Elevations: Some patients may experience elevated liver enzymes, which should be monitored regularly.\nDecreased Appetite: A reduction in appetite and weight loss may occur in some patients.\nFatigue: Tiredness and weakness are common, particularly during the initial stages of treatment.\nBleeding Events: There is an increased risk of bleeding, especially in patients taking anticoagulants.\n For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 795.0, "discountamount": 238.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2024-09-05T11:45:16.665Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintedanib-100-mg-/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": null, "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66695161c91739182c954a1d", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIRFENOID 200", "description": "PIRFENOID 200\nPirfenidone (200mg)\nPirfenidone 200mg is a medication containing the active ingredient Pirfenidone, prescribed primarily for treating idiopathic pulmonary fibrosis (IPF). It works by reducing fibrosis (scarring) in the lungs, thereby improving breathing and slowing disease progression. This medicine comes in tablet form with a standard dosage of 200mg. It is generally taken orally three times a day with food to enhance absorption and reduce stomach upset. Pirfenidone may cause side effects like nausea, diarrhea, rash, and fatigue. It's important to follow the prescribed dosage and consult a healthcare professional for guidance.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/pirfenoid-200-134484", "price": 329.0, "discountamount": 99.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IPF", "Call", "rash", "food", "ORDER", "Email", "lungs", "nausea", "product", "fatigue", "WhatsApp", "guidance", "diarrhea", "medicine", "PIRFENOID", "breathing", "medication", "absorption", "information", "tablet form", "sterisonline", "side effects", "sterispharma", "stomach upset", "standard dosage", "Pirfenidone 200mg", "active ingredient", "disease progression", "healthcare professional", "idiopathic pulmonary fibrosis" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1776, "imageuri": "https://productimages.withfloats.com/actual/66695164c9162f54a1557073.png", "tileimageuri": "https://productimages.withfloats.com/tile/66695164c9162f54a1557073.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T07:42:25.938Z", "updatedon": "2024-06-27T07:19:03.768Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pirfenoid-200/1776", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIRFENOID 200", "category": "RESPIRTORYRANGE", "tags": [ "PIRFENOID 200 price", "PIRFENOID 200 usses", "PIRFENOID 200 side effects", "pirfenidone 200 mg dosage", "Pirfenidone (200mg)", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66694f6bca84cd189c25ac3e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PIRFENOID 400", "description": "PIRFENOID 400\nPirfenidone (400mg)\nPirfenoid 400 is a medication containing 400mg of Pirfenidone, a drug used to treat idiopathic pulmonary fibrosis (IPF). It works by reducing lung scarring and inflammation, slowing disease progression. The usual dosage is 801mg thrice daily. Side effects may include nausea, rash, and fatigue. Follow your doctor's guidance for optimal results.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/pirfenoid-400-133743\n\n\n\n\n\n\n", "price": 439.0, "discountamount": 132.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IPF", "rash", "drug", "400mg", "ORDER", "Email", "801mg", "nausea", "doctor", "fatigue", "product", "guidance", "WhatsApp", "PIRFENOID", "medication", "Pirfenidone", "information", "sterispharma", "inflammation", "Side effects", "usual dosage", "sterisonline", "lung scarring", "optimal results", "disease progression", "idiopathic pulmonary fibrosis" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1774, "imageuri": "https://productimages.withfloats.com/actual/66694f6d5e294343790b2279.png", "tileimageuri": "https://productimages.withfloats.com/tile/66694f6d5e294343790b2279.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-12T07:34:03.278Z", "updatedon": "2024-06-27T07:14:45.807Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pirfenoid-400/1774", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PIRFENOID 400", "category": "RESPIRTORYRANGE", "tags": [ "Pirfenidone (400mg) price", "pirfenidone 400 mg uses in hindi", "pirfenidone 400 mg side effects in hindi", "pirfenidone (400mg) benefits" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66618cb9ea22b014e8af26c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NINTEDONE 150", "description": "NINTEDONE 150\nNintedanib (150mg)\nNintedanib 150mg is a medication used in the treatment of certain lung diseases such as idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and chronic fibrosing interstitial lung diseases (ILDs).\n\nNintedanib belongs to a class of drugs called tyrosine kinase inhibitors, which work by targeting specific enzymes involved in the formation of scar tissue in the lungs. By blocking these enzymes, nintedanib helps to slow down the progression of fibrosis and improve lung function.\n\nThe recommended dosage of nintedanib is usually 150mg taken orally twice daily with food, unless otherwise directed by a healthcare professional. It's important to take nintedanib consistently and at the same times each day to maximize its effectiveness.\n\nCommon side effects of nintedanib may include diarrhea, nausea, vomiting, abdominal pain, decreased appetite, and liver enzyme elevations. It's important to inform your doctor if you experience any severe or persistent side effects while taking nintedanib.\n\nNintedanib 150mg tablets are available by prescription only and should be used under the supervision of a healthcare provider. It's essential to follow your doctor's instructions regarding dosage and any additional monitoring required during treatment with nintedanib.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \nhttps://www.sterisonline.com/product/nintedone-150-133671\n\n\n\n\n\n\n", "price": 1050.0, "discountamount": 150.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "IPF", "ILDs", "food", "lungs", "drugs", "Email", "class", "ORDER", "nausea", "dosage", "severe", "doctor", "SSc-ILD", "appetite", "WhatsApp", "vomiting", "diarrhea", "formation", "treatment", "NINTEDONE", "same times", "medication", "supervision", "progression", "scar tissue", "prescription", "instructions", "sterispharma", "sterisonline", "effectiveness", "lung function", "abdominal pain", "specific enzymes", "healthcare provider", "Common side effects", "additional monitoring", "healthcare professional", "persistent side effects", "liver enzyme elevations", "Nintedanib 150mg tablets", "tyrosine kinase inhibitors", "idiopathic pulmonary fibrosis", "chronic fibrosing interstitial lung diseases", "systemic sclerosis-associated interstitial lung disease" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1448, "imageuri": "https://productimages.withfloats.com/actual/66618cbd0c19ea48b9484a3b.png", "tileimageuri": "https://productimages.withfloats.com/tile/66618cbd0c19ea48b9484a3b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T10:17:29.618Z", "updatedon": "2024-06-29T07:35:43.595Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintedone-150/1448", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 150", "category": "GENERAL RANGE", "tags": [ "NINTEDONE 150", "Nintedanib (150mg)", "Nintedanib 150 mg price in India", "Nintedanib 150 mg generic medicine", "Nintedanib 150 mg brands in India", "Nintedanib 150 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "662b9f97a4eb611de48dd113", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "NINTEDONE 150 ", "description": "NINTEDONE 150 \nNintedanib (150mg)\nNINTEDONE 150, containing Nintedanib at 150mg strength, is a targeted medication used in treating various lung diseases like idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD). Its mechanism involves blocking pathways that promote scarring and inflammation in lung tissue, thereby slowing disease progression and improving lung function. This prescription medicine is taken orally and is often part of a comprehensive treatment plan managed by healthcare professionals.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 1050.0, "discountamount": 150.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "ILD", "IPF", "part", "scarring", "pathways", "mechanism", "NINTEDONE", "Nintedanib", "lung tissue", "inflammation", "lung function", "150mg strength", "targeted medication", "disease progression", "prescription medicine", "various lung diseases", "healthcare professionals", "comprehensive treatment plan", "idiopathic pulmonary fibrosis", "other interstitial lung diseases" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 771, "imageuri": "https://productimages.withfloats.com/actual/662b9f99326a2039bea2891b.png", "tileimageuri": "https://productimages.withfloats.com/tile/662b9f99326a2039bea2891b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:35:35.162Z", "updatedon": "2024-06-07T12:33:31.379Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//nintedone-150-/771", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Nintedanib (150mg)", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6891f29bfb7044dfb2d43adf", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "MAGRAL 160", "description": "MAGRAL 160 is a pharmaceutical medication containing megestrol acetate 160 mg, a synthetic progestin known for its potent antineoplastic and appetite-stimulating properties. This drug is primarily prescribed to manage significant health challenges such as unexplained weight loss, anorexia, and cachexia, especially in patients suffering from chronic conditions like cancer or AIDS. Additionally, megestrol acetate functions as a hormone therapy agent employed in the treatment of certain hormone-sensitive malignancies. Its dual action both supports tumor management and improves patients' nutritional status by stimulating appetite and promoting weight gain, thereby enhancing overall quality of life. The drug is regarded as a crucial option in oncology and palliative care for managing complex conditions related to hormone-dependent cancers and severe wasting syndromes.\n\nWhat is MAGRAL 160?\nMAGRAL 160 is an oral medication formulated with megestrol acetate 160 mg, a synthetic progestin hormone derivative. It works primarily by modulating hormone receptors and altering hormone levels that influence the growth of hormone-responsive tumors such as breast and endometrial cancers. Apart from its antineoplastic action, it stimulates appetite by acting on the hypothalamic centers responsible for hunger, helping patients suffering from severe weight loss regain a healthy appetite and weight.\n\nUses of MAGRAL 160\n\nTo treat hormone-dependent cancers, specifically advanced breast cancer and endometrial cancer.\n\nTo stimulate appetite and promote weight gain in patients experiencing anorexia, cachexia, or unexplained severe weight loss related to chronic illnesses like cancer or AIDS.\n\nTo manage wasting syndromes that lead to malnutrition and significant weight loss.\n\nTo serve as an antineoplastic agent in hormone-sensitive malignancies.\n\nIn short, MAGRAL 160 is primarily used to treat anorexia and cachexia or serious unexplained weight loss and is also used as an antineoplastic agent to treat certain types of malignancy.\n\nSide Effects of MAGRAL 160\n\nWeight gain (often desirable but can be excessive)\n\nFluid retention and edema (swelling)\n\nNausea and vomiting\n\nDiarrhea or constipation\n\nVaginal bleeding or spotting in women\n\nFatigue, weakness, and insomnia\n\nHeadache and dizziness\n\nIncreased risk of blood clots (deep vein thrombosis or pulmonary embolism)\n\nHormonal imbalances, such as decreased sex hormone levels, which can lead to sexual dysfunction or bone density loss\n\nAllergic reactions including rash or itching\n\nPatients should report severe or unusual symptoms, especially signs of blood clots such as limb swelling, chest pain, or sudden shortness of breath, immediately to their healthcare provider.\n\nPrecautions before Using MAGRAL 160\n\nInform your doctor if you are pregnant, breastfeeding, or planning to conceive as MAGRAL 160 is contraindicated in pregnancy.\n\nDisclose any history of blood clots, cardiovascular diseases, liver or kidney impairment.\n\nPatients with diabetes should monitor blood sugar closely as megestrol acetate may cause hyperglycemia.\n\nAvoid sudden discontinuation without medical advice to prevent potential hormonal withdrawal effects.\n\nRegular monitoring is required, including hormone levels and blood tests, to assess efficacy and safety during treatment.\n\nUse cautiously in patients at risk for deep vein thrombosis or pulmonary embolism due to increased clotting risks.\n\nDrug Interactions: What Drugs Interact with MAGRAL 160?\n\nCYP3A4 enzyme inducers (e.g., rifampin, phenytoin) may reduce the effectiveness of megestrol acetate by increasing its metabolism.\n\nConcurrent use with blood thinners (anticoagulants) requires careful monitoring as MAGRAL 160 might influence clotting parameters.\n\nCombining with drugs that affect hormonal pathways, such as other hormonal therapies or corticosteroids, may alter treatment outcomes.\n\nInteractions with diabetes medications might necessitate dose adjustment due to potential effects on blood sugar control.\n\nCareful medical supervision is necessary when used with immunosuppressants or other chemotherapy agents to avoid additive side effects or altered drug levels.\n\nConclusion\nMAGRAL 160, containing megestrol acetate 160 mg, is a clinically validated medication widely used to manage complex conditions such as hormone-dependent cancers as well as severe weight loss due to anorexia and cachexia. Its unique ability to act both as an antineoplastic agent and an appetite stimulant makes it invaluable in improving patient outcomes, nutritional status, and overall quality of life. Patients prescribed MAGRAL 160 should adhere strictly to their healthcare provider’s instructions and report any adverse effects promptly. This medication should always be used under medical supervision to ensure optimal benefits and minimize risks.", "price": 810.0, "discountamount": 243.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2156, "imageuri": "https://productimages.withfloats.com/actual/6891f2a0115b51057b971998.png", "tileimageuri": "https://productimages.withfloats.com/tile/6891f2a0115b51057b971998.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-08-05T12:01:31.195Z", "updatedon": "2025-08-05T12:01:31.195Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/magral-160/2156", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "megestrol acetate 160 mg", "category": "Gynaecology", "tags": [ "megestrol acetate 160 mg" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6864fe81c4418d1ebb0d08eb", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "STERIS DPI DEVICE", "description": "The STERIS DPI DEVICE is a modern, user-friendly Dry Powder Inhaler (DPI) designed to deliver respiratory medication directly to the lungs in a highly efficient and portable form. Inhalation therapy plays a critical role in the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The DPI device simplifies this process by delivering the drug in the form of a dry powder without the need for coordination between actuation and inhalation, making it ideal for patients of all ages.\n\nWhat is a DPI Device?\nA Dry Powder Inhaler (DPI) is a medical device used to deliver therapeutic medication directly into the lungs. Unlike traditional inhalers that use propellants to push the drug into the lungs, DPI devices rely on the patient’s own inhalation power to disperse and inhale the powdered drug effectively. Essentially, a DPI device is a tool that administers medication in dry powder form to the lungs, providing quick and targeted respiratory relief.\n\nDPI Full Form: Dry Powder Inhaler\n\nUses of STERIS DPI DEVICE\nThe STERIS DPI DEVICE is commonly used in the treatment and management of respiratory diseases such as:\n\nAsthma\n\nChronic Obstructive Pulmonary Disease (COPD)\n\nBronchitis\n\nAllergic airway conditions\n\nIt helps deliver medication directly to the airways, ensuring faster action and reduced systemic side effects compared to oral treatments.\n\nHow It Works\nWhen the patient inhales through the mouthpiece, the device uses the airflow to disperse the dry powder into fine particles, allowing it to reach deep into the lungs. The inhaled medication begins working quickly to open airways, reduce inflammation, or treat infection, depending on the formulation used with the DPI.\n\nSide Effects of Dry Powder Inhaler Use\nWhile the STERIS DPI DEVICE itself is safe and user-friendly, some medications delivered via DPI may cause minor side effects such as:\n\nDry throat or mouth\n\nHoarseness\n\nCough\n\nIrritation in the throat\n\nFungal infections in the mouth (if corticosteroids are used and mouth is not rinsed after use)\n\nThese side effects can often be minimized with proper usage and hygiene.\n\nPrecautions Before Using STERIS DPI DEVICE\nAlways read the instructions carefully before first-time use.\n\nMake sure the device is clean and free from moisture.\n\nInhale deeply and forcefully to ensure proper medication delivery.\n\nDo not exhale into the device, as moisture can affect the powder's consistency.\n\nStore in a dry, cool place away from direct sunlight.\n\nAlways rinse your mouth after using corticosteroid-based powders.\n\nAdvantages of STERIS DPI DEVICE\nPropellant-free and eco-friendly\n\nPortable and compact design for daily use\n\nNo coordination required between inhalation and actuation\n\nDelivers medication effectively with minimal effort\n\nEasy-to-use, even for elderly or pediatric patients\n\nConclusion\nThe STERIS DPI DEVICE is a highly effective solution for individuals suffering from chronic or acute respiratory disorders. By delivering medication directly to the lungs in a dry powder form, it ensures fast relief, greater bioavailability, and improved patient compliance. Whether you’re managing asthma or COPD, this DPI device offers a dependable and convenient way to breathe easier every day.", "price": 255.0, "discountamount": 77.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "coordination required", "inhalation power", "inhalation making", "breathe easier", "individuals suffering", "compact design", "ecofriendly portable", "direct sunlight", "instructions carefully", "hygiene precautions", "proper usage", "medications delivered", "reach deep", "oral treatments", "critical role", "medical device", "patient inhales", "administers medication", "highly efficient", "respiratory diseases", "dpi device", "dry throat", "dry powder", "side effects", "moisture inhale deeply", "delivering medication directly", "lungs providing quick", "dry powder form", "chronic respiratory conditions", "pediatric patients conclusion", "dpi device offers", "dpi device simplifies", "steris dpi device", "dpi side effects", "youre managing asthma", "dry powder inhaler", "minor side effects", "improved patient compliance", "highly effective solution", "throat fungal infections", "dry cool place", "acute respiratory disorders", "minimal effort easytouse", "corticosteroidbased powders advantages", "powders consistency store", "treat infection depending", "fine particles allowing" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2142, "imageuri": "https://productimages.withfloats.com/actual/6864feb4c75fa610aeaeaeda.png", "tileimageuri": "https://productimages.withfloats.com/tile/6864feb4c75fa610aeaeaeda.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-07-02T09:40:17.078Z", "updatedon": "2025-07-02T13:03:34.654Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/steris-dpi-device/2142", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Dry powder inhaler", "category": "RESPIRTORYRANGE", "tags": [ "Dry powder inhaler" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6819e619af35b11ab7f87163", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "BUDEPRESS FORTE 400 CAPSULES", "description": "BUDEPRESS FORTE 400 combines powerful inhalation therapy ingredients to manage asthma and chronic obstructive pulmonary disease (COPD). This medication contains Formoterol Fumarate (12 mcg) and Budesonide IP (400 mcg), working together to alleviate and prevent respiratory symptoms including wheezing, shortness of breath, chest constriction, and chronic coughing. It delivers both sustained control and quick symptom relief, enhancing lung function and life quality.\nActive Components:\nFormoterol Fumarate (12 mcg)\nA long-acting beta-2 adrenergic agonist (LABA) that delivers quick and extended bronchodilation by relaxing airway muscles. Effects begin within minutes and continue for up to 12 hours, making it excellent for ongoing therapy.\nBudesonide IP (400 mcg)\nA strong inhaled corticosteroid (ICS) that reduces lung inflammation, swelling, and mucus production—primary factors contributing to asthma and COPD symptoms.\nPrimary Advantages:\nCombination therapy featuring both bronchodilator and anti-inflammatory for comprehensive respiratory management.\nQuick relief from bronchial constriction and breathing difficulties.\nExtended symptom control lasting up to 12 hours with regular administration.\nReduces asthma attack frequency and COPD flare-up severity.\nEnhances respiratory function for easier, more comfortable breathing.\nRequires fewer daily doses compared to short-acting alternatives.\nAppropriate for moderate to severe respiratory conditions under medical guidance.\nMechanism of Action:\nBUDEPRESS FORTE 400 operates through complementary actions of its two key ingredients:\nFormoterol Fumarate eases bronchial tube smooth muscles, creating airway expansion and rapid relief from narrowing that causes breathing distress.\nBudesonide, as an anti-inflammatory steroid, addresses underlying airway inflammation causing chronic symptoms and exacerbations. It diminishes hyperresponsiveness and mucus accumulation with consistent use.\nTogether, they prevent airway tightening, decrease inflammation, and facilitate smooth airflow, offering better management of chronic respiratory conditions.\nUsage Instructions:\nUse only as prescribed by your healthcare provider.\nTypically administered twice daily (morning and evening), though dosage may vary based on condition severity and individual response.\nShake inhaler thoroughly before each use.\nRinse mouth completely with water after each use to avoid oral thrush (fungal infection).\nNever exceed the prescribed dosage.\nFor effective management, maintain consistent use even when symptoms improve.\nPotential Side Effects:\nMost patients tolerate BUDEPRESS FORTE 400 well, though side effects may occur:\nCommon Effects:\n\nVoice changes or hoarseness\nDry mouth or throat irritation\nCoughing or throat discomfort\nHeadache\nMild trembling or shakiness\nElevated heart rate (palpitations)\n\nLess Common but Serious Effects:\n\nOral or throat fungal infection (thrush)\nAllergic responses (rash, swelling, breathing difficulty)\nMuscle cramping\nChest discomfort\nWorsening respiratory issues (paradoxical bronchospasm)\n\nContact your physician immediately for persistent or severe side effects.\nImportant Precautions:\nNot for acute asthma attack treatment—always maintain a rescue inhaler for emergencies.\nInform your doctor about heart conditions, diabetes, thyroid disorders, or liver issues.\nAvoid exposure to contagious diseases (e.g., chickenpox, measles) while using corticosteroid therapy.\nPregnant or nursing women should consult healthcare providers before using.\nStore securely away from children.\nBUDEPRESS FORTE 400 provides a clinically validated, dual-action approach to respiratory comfort—combining immediate relief with long-term management. With proper medical supervision, it significantly improves daily activity levels and decreases respiratory symptom burden.", "price": 940.0, "discountamount": 282.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": [ "12 hours", "prescribed dosage", "longterm management", "rapid relief", "12 hours making", "delivers quick", "manage asthma", "store securely", "nursing women", "chickenpox measles", "contagious diseases", "emergencies inform", "rescue inhaler", "physician immediately", "effects oral", "side effects", "condition severity", "vary based", "daily morning", "mucus accumulation", "diminishes hyperresponsiveness", "complementary actions", "shortacting alternatives", "extended bronchodilation", "sustained control", "wheezing shortness", "bronchial constriction", "chronic coughing", "respiratory comfortcombining", "throat irritation coughing", "breath chest constriction", "severe respiratory conditions", "prevent respiratory symptoms", "proper medical supervision", "consult healthcare providers", "corticosteroid therapy pregnant", "hoarseness dry mouth", "rinse mouth completely", "breathing distress budesonide", "medical guidance mechanism" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2101, "imageuri": "https://productimages.withfloats.com/actual/6819e61c974ab387c1d08df8.png", "tileimageuri": "https://productimages.withfloats.com/tile/6819e61c974ab387c1d08df8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-05-06T10:36:09.795Z", "updatedon": "2025-05-06T10:36:09.795Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/budepress-forte-400-capsules/2101", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Formoterol Fumarate (12 mcg), Budesonide IP (400 mcg)", "category": "ASTHMARANGE", "tags": [ "Formoterol fumarate and budesonide powder for inhalation ip", "Formoterol fumarate and Budesonide powder for inhalation ip uses", "Formoterol fumarate and budesonide inhaler dosage", "Formoterol fumarate and Budesonide Powder for Inhalation IP 400" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }